Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)
PHASE1
The purpose of this study is to evaluate the safety, tolerability and clini...
A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
PHASE2
The purpose of this study is to learn about the effects of 3 study medicine...
PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC
N/A
Solid cancers and their therapeutic management remain a major public health...
Status
Recruiting
Location
Angers University Hospital
Start Date
2025-12-17
Trial ID
NCT06195527
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
PHASE3
The purpose of this study is to assess the efficacy and safety of pembroliz...
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
PHASE3
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...